These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26857995)

  • 1. AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II.
    Ko AR; Jin DK; Cho SY; Park SW; Przybylska M; Yew NS; Cheng SH; Kim JS; Kwak MJ; Kim SJ; Sohn YB
    Mol Genet Metab; 2016 Apr; 117(4):447-55. PubMed ID: 26857995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.
    Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S
    Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.
    Kudo M; Brem MS; Canfield WM
    Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.
    Paton L; Bitoun E; Kenyon J; Priestman DA; Oliver PL; Edwards B; Platt FM; Davies KE
    J Biol Chem; 2014 Sep; 289(39):26709-26721. PubMed ID: 25107912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations.
    Velho RV; Harms FL; Danyukova T; Ludwig NF; Friez MJ; Cathey SS; Filocamo M; Tappino B; Güneş N; Tüysüz B; Tylee KL; Brammeier KL; Heptinstall L; Oussoren E; van der Ploeg AT; Petersen C; Alves S; Saavedra GD; Schwartz IV; Muschol N; Kutsche K; Pohl S
    Hum Mutat; 2019 Jul; 40(7):842-864. PubMed ID: 30882951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pathology of murine mucolipidosis types II and IIIC.
    Vogel P; Payne BJ; Read R; Lee WS; Gelfman CM; Kornfeld S
    Vet Pathol; 2009 Mar; 46(2):313-24. PubMed ID: 19261645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.
    Wang Y; Ye J; Qiu WJ; Han LS; Gao XL; Liang LL; Gu XF; Zhang HW
    Acta Pharmacol Sin; 2019 Feb; 40(2):279-287. PubMed ID: 29872134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
    Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
    J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene.
    Cury GK; Matte U; Artigalás O; Alegra T; Velho RV; Sperb F; Burin MG; Ribeiro EM; Lourenço CM; Kim CA; Valadares ER; Galera MF; Acosta AX; Schwartz IV
    Gene; 2013 Jul; 524(1):59-64. PubMed ID: 23566849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.
    Cathey SS; Leroy JG; Wood T; Eaves K; Simensen RJ; Kudo M; Stevenson RE; Friez MJ
    J Med Genet; 2010 Jan; 47(1):38-48. PubMed ID: 19617216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.
    Ho CC; Tsung LL; Liu KT; Poon WT
    BMC Med Genet; 2018 Sep; 19(1):162. PubMed ID: 30208878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of 30 novel pathogenic variations in 69 unrelated Indian patients with Mucolipidosis Type II and Type III.
    Pasumarthi D; Gupta N; Sheth J; Jain SJMN; Rungsung I; Kabra M; Ranganath P; Aggarwal S; Phadke SR; Girisha KM; Shukla A; Datar C; Verma IC; Puri RD; Bhavsar R; Mistry M; Sankar VH; Gowrishankar K; Agrawal D; Nair M; Danda S; Soni JP; Dalal A
    J Hum Genet; 2020 Nov; 65(11):971-984. PubMed ID: 32651481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB).
    De Pace R; Coutinho MF; Koch-Nolte F; Haag F; Prata MJ; Alves S; Braulke T; Pohl S
    Hum Mutat; 2014 Mar; 35(3):368-76. PubMed ID: 24375680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma.
    Liu S; Zhang W; Shi H; Meng Y; Qiu Z
    Gene; 2014 Feb; 535(2):294-8. PubMed ID: 24316125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis.
    Yang M; Cho SY; Park HD; Choi R; Kim YE; Kim J; Lee SY; Ki CS; Kim JW; Sohn YB; Song J; Jin DK
    Orphanet J Rare Dis; 2017 Jan; 12(1):11. PubMed ID: 28095893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms.
    Ludwig NF; Velho RV; Sperb-Ludwig F; Acosta AX; Ribeiro EM; Kim CA; Gandelman Horovitz DD; Boy R; Rodovalho-Doriqui MJ; Lourenço CM; Santos ES; Braulke T; Pohl S; Schwartz IVD
    Int J Biochem Cell Biol; 2017 Nov; 92():90-94. PubMed ID: 28918368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III.
    Di Lorenzo G; Westermann LM; Yorgan TA; Stürznickel J; Ludwig NF; Ammer LS; Baranowsky A; Ahmadi S; Pourbarkhordariesfandabadi E; Breyer SR; Board TN; Foster A; Mercer J; Tylee K; Velho RV; Schweizer M; Renné T; Braulke T; Randon DN; Sperb-Ludwig F; de Camargo Pinto LL; Moreno CA; Cavalcanti DP; Amling M; Kutsche K; Winter D; Muschol NM; Schwartz IVD; Rolvien T; Danyukova T; Schinke T; Pohl S
    Genet Med; 2021 Dec; 23(12):2369-2377. PubMed ID: 34341521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease).
    Wang P; Mazrier H; Caverly Rae J; Raj K; Giger U
    BMC Vet Res; 2018 Dec; 14(1):416. PubMed ID: 30591066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma.
    Westermann LM; Fleischhauer L; Vogel J; Jenei-Lanzl Z; Ludwig NF; Schau L; Morellini F; Baranowsky A; Yorgan TA; Di Lorenzo G; Schweizer M; de Souza Pinheiro B; Guarany NR; Sperb-Ludwig F; Visioli F; Oliveira Silva T; Soul J; Hendrickx G; Wiegert JS; Schwartz IVD; Clausen-Schaumann H; Zaucke F; Schinke T; Pohl S; Danyukova T
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 33023972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.
    Idol RA; Wozniak DF; Fujiwara H; Yuede CM; Ory DS; Kornfeld S; Vogel P
    PLoS One; 2014; 9(10):e109768. PubMed ID: 25314316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.